Microba Life Sciences Limited

ASX:MAP.AX

0.17 (AUD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

202420232022202120202019
Operating Activities:
Net Income -19.938-12.68-11.47-7.524-6.651-4.734
Depreciation & Amortization 2.871.6421.5431.2181.0910.765
Deferred Income Tax 0-5.696-3.973-3.744-0.0070.013
Stock Based Compensation 00.4210.6420.5630.4670.183
Change In Working Capital 0.992-1.619-0.253-1.2880.8020.121
Accounts Receivables -0.01-3.814-1.773-1.027-0.460.245
Inventory -0.311-0.2840.153-0.172-0.171-0.164
Accounts Payables 0.2092.1061.3740.4550.5480.336
Other Working Capital 1.1040.372-0.007-0.5430.885-0.297
Other Non Cash Items 6.3625.5393.0633.5942.7071.326
Operating Cash Flow -15.567-12.394-10.449-7.182-4.323-3.621
Investing Activities:
Investments In Property Plant And Equipment -4.379-3.037-1.873-0.672-0.856-0.836
Acquisitions Net -9.5700.009000.002
Purchases Of Investments 00-0.154000
Sales Maturities Of Investments 000.228000
Other Investing Activites -2.8920.0380.0580.15-0.495-0.702
Investing Cash Flow -13.949-2.999-1.732-0.522-0.856-0.834
Financing Activities:
Debt Repayment -0.06-0.005-0.224-0.141-0.125-0.145
Common Stock Issued 20.35717.23831.2514.1941.410.562
Common Stock Repurchased -1.257-0.596-1.905000
Dividends Paid 000000
Other Financing Activities -0.7650.6430.5214.1940.0143.3
Financing Cash Flow 18.39416.68429.21613.8361.08113.717
Other Information:
Effect Of Forex Changes On Cash -0.0320.1710.567-0.0501.733
Net Change In Cash -11.1541.25917.6026.132-4.09810.995
Cash At End Of Period 20.88932.04430.58113.0296.89710.995